Beware competitors: pharmaceutical behemoths are closing in. Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735,...
Johnson & Johnson
Category
Canadian Government Continues to Add to COVID-19 Vaccine Candidate Portfolio Inking Deals with Novavax & J&J
Canada continues to execute on an intense COVID-19 vaccine diversification strategy, led by Prime Minister Justin Trudeau, as just weeks ago the entire nation was left with no vaccine access after China’s CanSino Biologics wasn’t able to deliver the agreed upon...
Unprecedented Deal Making Continues as J&J Secures $1+ Billion for COVID-19 Vaccine Ad26.COV2.S
The U.S. federal government via Operation Warp Speed’s “BARDA” continues deal making at unprecedented levels, now entering into an arrangement with U.S. pharmaceutical giant Johnson & Johnson’s Janssen Pharmaceuticals Group, to procure 100 million doses of...
1.4M may Die from TB due to COVID-19 Pandemic as J&J Cuts its Drug Price but Doctors without Borders Declares Need for Deeper Discount
Johnson & Johnson (J&J) slashed pricing for its tuberculosis drug bedaquiline to $340 from $400 for a six month treatment in low-and middle-income countries to scale up the drug’s use during the COVID-19 pandemic. Sold under the brand name Sirturo, the drug...
J&J (Janssen) Picks up Speed with Ad26.COV2-S COVID-19 Vaccine: A Giant is in the Race
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S,...
Will a J&J Vaccine be Ready in 2020? Walking on a Thin Line in Big Pharma
In February, corporate heavy weight Johnson & Johnson announced its entry into the SARS-CoV-2 vaccine race in partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA). The American pharmaceutical giant reported it had been working...
Rutgers New Jersey Medical School Research Center Participates ongoing in HIV Vaccine Study Praised by Dr. Fauci
Rutgers New Jersey Medical School Clinical Research Center represents the only clinical investigational site in New Jersey to participate in the Phase III HIV vaccine clinical trial known as MOSAICO. Dr. Anthony Fauci, Director of the National Institute of...
J&J Teams with HHS BARDA to Develop COVID-19 Vaccine Forecasted for One Year Out
American pharmaceutical giant Johnson & Johnson (NYSE: JNJ) announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between he Janssen...
64-Year Old North Carolina Grandmother is the First in U.S. to Participate in Microwave Ablation Clinical Trial at First Health Carolinas
Clinical research as a care option comes to Pinehurst Medical Clinic in central North Carolina. Terri Cook, a substitute teacher and grandmother living in North Carolina, had her upper right lobe removed after a lung cancer surgery in 2015. Cook was a non-smoker....
Johnson & Johnson and Apple Launching Virtual Study to Improve AFib Outcomes
Johnson & Johnson will benefit from the recent Apple and Stanford “App” study as they prepare to collaborate with Apple to assess the impact of wearable technology on earlier detection of AFib as well as the goal to improve diagnosis and patient outcomes. Up to...
Report: Johnson & Johnson Suppressed Key Facts of the Faulty Hip Replacements Sold in India
The Indian arm of Johnson &Johnson 'suppressed' key facts regarding the recall and compensation of the faulty hip replacement systems it sold in India, an expert committee set up by the Union Ministry of Health & Family Welfare said in a report. The expert...